-
1
المصدر: Frontiers in Pharmacology. 13
مصطلحات موضوعية: immune checkpoint inhibitors, LAG-3, PD-1, CTLA-4, atherosclerosis, immune checkpoints, myocarditis, cardiomyopathy
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=dris___01423::047416ea2081cfd6becc28dab1a61bb4Test
https://research.rug.nl/en/publications/7236c6b4-d53f-441b-b6ca-0bcd00136832Test -
2
المصدر: Frontiers in Pharmacology. 13
مصطلحات موضوعية: immune checkpoint inhibitors, Pharmacology, SDG 3 - Good Health and Well-being, LAG-3, PD-1, CTLA-4, Pharmacology (medical), atherosclerosis, immune checkpoints, myocarditis, cardiomyopathy
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7835edbbecaeadd323a6c31d88d39f7bTest
https://doi.org/10.3389/fphar.2022.989431Test -
3دورية أكاديمية
المؤلفون: Steinberger, Peter, Stecher, Carmen, Battin, Claire, Leitner, Judith, Zettl, Markus, Grabmeier-Pfistershammer, Katharina, Höller, Christoph, Zlabinger, Gerhard J.
مصطلحات موضوعية: PD-1, TIM-3, BTLA, CD160, LAG-3, CTLA-4, immune checkpoint, coinhibitory receptors
وصف الملف: text/html
العلاقة: vignette : https://repositorium.meduniwien.ac.at/titlepage/urn/urn:nbn:at:at-ubmuw:3-15128/128Test; urn:nbn:at:at-ubmuw:3-15128; https://resolver.obvsg.at/urn:nbn:at:at-ubmuw:3-15128Test; local:99145322734603331; system:AC15623241
الإتاحة: https://doi.org/10.3389/fimmu.2017.00572Test
https://resolver.obvsg.at/urn:nbn:at:at-ubmuw:3-15128Test -
4
المؤلفون: Giuseppe Bronte, Alberto Verlicchi, Serena De Matteis, Alice Rossi, Alessandra Affatato, Francesco Giulio Sullo, Caterina Gianni, Matteo Canale, Marco Angelo Burgio, Angelo Delmonte, Michele Milella, Lucio Crinò
المصدر: Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)مصطلحات موضوعية: Male, 0301 basic medicine, Lung Neoplasms, Myeloid, medicine.medical_treatment, Immunology, immune checkpoint inhibitor, Adenocarcinoma of Lung, Case Report, chemical and pharmacologic phenomena, 03 medical and health sciences, 0302 clinical medicine, Immune system, Cancer immunotherapy, LAG-3, Antineoplastic Combined Chemotherapy Protocols, PD-1, medicine, Humans, Immunology and Allergy, Lung cancer, Immune Checkpoint Inhibitors, Aged, T cell exhaustion, business.industry, Cancer, RC581-607, Middle Aged, biochemical phenomena, metabolism, and nutrition, myeloid-derived suppressor cells, medicine.disease, Ipilimumab, Immune checkpoint, Nivolumab, 030104 developmental biology, medicine.anatomical_structure, CTLA-4, 030220 oncology & carcinogenesis, Cancer research, Myeloid-derived Suppressor Cell, Tumor Escape, Immunologic diseases. Allergy, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5ad11e5b5cf86e4ec09d57949b4bf71Test
https://doi.org/10.3389/fimmu.2021.672219Test -
5
المؤلفون: Xuan Zeng, Xiaohua Shi, Yuanyuan Liu, Shafei Wu, Feng Mao, Yufeng Luo, Xuefei Wang, Jing Wang
المصدر: Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)مصطلحات موضوعية: lcsh:Immunologic diseases. Allergy, PD-L1, 0301 basic medicine, Population, Immunology, Gene Expression, Triple Negative Breast Neoplasms, DNA Mismatch Repair, B7-H1 Antigen, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, LAG-3, Antigens, CD, medicine, Humans, Immunology and Allergy, education, In Situ Hybridization, Fluorescence, Triple-negative breast cancer, Original Research, Aged, Mismatch Repair Endonuclease PMS2, Retrospective Studies, education.field_of_study, Predictive marker, biology, business.industry, Microsatellite instability, CD8, Middle Aged, medicine.disease, Immunohistochemistry, Lymphocyte Activation Gene 3 Protein, DNA-Binding Proteins, MutS Homolog 2 Protein, 030104 developmental biology, 030220 oncology & carcinogenesis, triple-negative breast cancer, Cancer research, biology.protein, Female, Microsatellite Instability, DNA mismatch repair, lcsh:RC581-607, MutL Protein Homolog 1, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34f8638be7b5d5c3455a7f2a20b9865dTest
-
6
المؤلفون: Thorsten Fuereder, Christoph Krall, Gabriela Kornek, Leonhard Müllauer, Felicitas Oberndorfer, Christina Wagner, Christoph Minichsdorfer
المصدر: Frontiers in Oncology, Vol 9 (2019)
Frontiers in Oncologyمصطلحات موضوعية: PD-L1, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Population, lcsh:RC254-282, 03 medical and health sciences, 0302 clinical medicine, LAG-3, Internal medicine, PD-1, Medicine, education, Original Research, education.field_of_study, biology, Tumor-infiltrating lymphocytes, business.industry, nasopharyngeal carcinoma, Hazard ratio, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Confidence interval, Log-rank test, 030104 developmental biology, Nasopharyngeal carcinoma, 030220 oncology & carcinogenesis, Cohort, biology.protein, Caucasian population, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da1e624e5450e2db09042ac5b9da677cTest
https://doi.org/10.3389/fonc.2019.01334Test -
7
المؤلفون: Carmen Stecher, Markus Zettl, Judith Leitner, Gerhard J. Zlabinger, Christoph Höller, Katharina Grabmeier-Pfistershammer, Claire Battin, Peter Steinberger
المصدر: Frontiers in Immunology, Vol 8 (2017)
Frontiers in Immunologyمصطلحات موضوعية: lcsh:Immunologic diseases. Allergy, 0301 basic medicine, TIM-3, medicine.medical_treatment, T cell, Immunology, BTLA, Biology, 03 medical and health sciences, Immune system, TIGIT, LAG-3, PD-1, medicine, Immunology and Allergy, immune checkpoint, Original Research, Immune checkpoint, Blockade, 030104 developmental biology, Cytokine, medicine.anatomical_structure, CTLA-4, Cancer research, coinhibitory receptors, CD160, lcsh:RC581-607
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4ec9ea01fa5df685b161b8c21f62d55Test
https://doi.org/10.3389/fimmu.2017.00572Test -
8
المؤلفون: Randolph J. Noelle, Isabelle Le Mercier, J. Louise Lines
المصدر: Frontiers in Immunology, Vol 6 (2015)
Frontiers in Immunologyمصطلحات موضوعية: lcsh:Immunologic diseases. Allergy, TIGIT, TIM-3, medicine.medical_treatment, Immunology, VISTA, Review, Bioinformatics, medicine.disease_cause, Autoimmunity, Immune system, Cancer immunotherapy, LAG-3, Blocking antibody, Immunology and Allergy, Medicine, BTLA, cancer immunotherapy, negative checkpoint regulators, business.industry, autoimmunity, Immunotherapy, Transplantation, CTLA-4, lcsh:RC581-607, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d25e0e7270a8248ecf246aefe692a10Test
https://doi.org/10.3389/fimmu.2015.00418Test